Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147923 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Belen Crespo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department Animal Physiology, Veterinary Medicine School, Complutense University of Madrid (UCM), 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Tosyl Compounds, Nitriles, Anilides, Inflammatory Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III., Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Human inflammatory breast cancer (IBC) and canine inflammatory mammary cancer (IMC) are highly aggressive neoplastic diseases that share numerous characteristics. In IBC and IMC, chemotherapy produces a limited pathological response and anti-androgen therapies have been of interest for breast cancer treatment. Therefore, the aim was to evaluate the effect of a therapy based on bicalutamide, a non-steroidal anti-androgen, with doxorubicin and docetaxel chemotherapy on cell proliferation, migration, tumor growth, and steroid-hormone secretion. An IMC-TN cell line, IPC-366, and an IBC-TN cell line, SUM149, were used. In vitro assays revealed that SUM149 exhibited greater sensitivity, reducing cell viability and migration with all tested drugs. In contrast, IPC-366 exhibited only significant in vitro reductions with docetaxel as a single agent or in different combinations. Decreased estrogen levels reduced in vitro tumor growth in both IMC and IBC. Curiously, doxorubicin resulted in low efficacy, especially in IMC. In addition, all drugs reduced the tumor volume in IBC and IMC by increasing intratumoral testosterone (T) levels, which have been related with reduced tumor progression. In conclusion, the addition of bicalutamide to doxorubicin and docetaxel combinations may represent a potential treatment for IMC and IBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Animal Physiology, Veterinary Medicine School, Complutense University of Madrid (UCM), 28040 Madrid, Spain.
- Obstetrics and Gynecology Department, Hospital Clinico San Carlos, Instituto de Salud de la Mujer, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IsISSC), 28040 Madrid, Spain.
- Department of Public and Maternal Child Health University, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
- Department of Surgical Pathology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
- Department of Animal Medicine, Surgery and Pathology, Veterinary Medicine School, Complutense University of Madrid, 28040 Madrid, Spain.
ORCID-Profile: Belen Crespo, María Herrera de la Muela, Miriam de la Puente Yague, Cristina Diaz Del Arco, Paloma Jimena de Andrés, Sara Caceres
Förderung
- Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III.
- Ministerio de Ciencias, Innovación y Universidades. Instituto de Salud Carlos III
Zitieren
APA
Crespo, B., Illera, J. C., Silvan, G., Lopez-Plaza, P., Herrera de la Muela, M., de la Puente Yague, M., Diaz Del Arco, C., de Andrés, P. J., Illera, M. J., & Caceres, S. (2024). Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147923
Vancouver
Crespo B, Illera JC, Silvan G, Lopez-Plaza P, Herrera de la Muela M, de la Puente Yague M, et al. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147923
BibTeX
@article{Crespo2024,
author = {Crespo, Belen and Illera, Juan Carlos and Silvan, Gema and Lopez-Plaza, Paula and Herrera de la Muela, María and de la Puente Yague, Miriam and Diaz Del Arco, Cristina and de Andrés, Paloma Jimena and Illera, Maria Jose and Caceres, Sara},
title = {Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147923}
}
EUVIMED